Jennifer R. Rider, ScD, MPH
Assistant Professor
Boston University School of Public Health
Dept of Epidemiology

ScD, Harvard School of Public Health
MPH, University of Massachusetts Amherst

My primary research interests are in prostate cancer epidemiology and the identification of patient and tumor characteristics that could reduce overdiagnosis and overtreatment. Collaborating with research pathologists, urologists, medical oncologists, molecular biologists, immunologists, virologists, and bioinformaticists, I have utilized data from a large Swedish population-based studies (CaPS and PCBaSe) and a Swedish randomized trial (SPCG-4), Swedish clinical cohorts, the Physicians’ Health Study, and the Health Professionals Follow-up Study. I am also involved in ongoing studies of HPV infection in penile carcinoma and am pursuing projects that investigate malignancies in HIV-infected populations.

2016 European Urology: Top 5 Most Downloaded Papers of 2016
2013 Harvard Medical School: The Eleanor and Miles Shore 50th Anniversary Fellowship Program for Scholars in Medicine
2013 European Urology: Best Clinical Research Paper of 2013
2012-2015 Prostate Cancer Foundation: Michael and Lori Milken-PCF Young Investigator Award
2012 American Urological Association, AUA Annual Meeting: Best Poster in Session
2012 Prostate Cancer Foundation, American Urological Association Annual Meeting: First Place Abstract
2011-2013 Harvard School of Public Health: Teaching Commendation
2009-2015 National Cancer Institute: NIH Loan Repayment Program Recipient
2008-2009 American Association of Cancer Research: Scholar-in-Training Award
2007 Harvard College: Certificate of Distinction in Teaching
2006 American Association of Cancer Research: Scholar-in-Training Award
2005 American Urological Association: Travel Award

Racial Differences in Splice Variants in Men with Localized Prostate Cancer
03/01/2018 - 02/28/2019 (PI)
Massachusetts General Hospital

Yr Title Project-Sub Proj Pubs
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Ahearn TU, Peisch S, Pettersson A, Ebot EM, Zhou CK, Graff RE, Sinnott JA, Fazli L, Judson GL, Bismar TA, Rider JR, Gerke T, Chan JM, Fiorentino M, Flavin R, Sesso HD, Finn S, Giovannucci EL, Gleave M, Loda M, Li Z, Pollak M, Mucci LA. Expression of IGF/insulin receptor in prostate cancer tissue and progression to lethal disease. Carcinogenesis. 2018 Dec 31; 39(12):1431-1437. PMID: 30165429.
  2. Vicier C, Werner L, Chipman J, Harshman LC, Patil DH, Fichorova RN, Rider JR, Sanda MG, Mucci LA, Sweeney CJ. Elevated Serum Cytokines and Trichomonas vaginalis Serology at Diagnosis Are Not Associated With Higher Gleason Grade or Lethal Prostate Cancer. Clin Genitourin Cancer. 2019 Feb; 17(1):32-37. PMID: 30348512.
  3. Johnson-Obaseki S, Caulley L, Corsten M, Liu G, Dimitroulakos J, Goldstein D, Irish J, Rider J. C-reactive Protein in HPV-Positive and HPV-Negative Oropharyngeal Cancer. Otolaryngol Head Neck Surg. 2018 Sep 18; 194599818800297. PMID: 30226795.
  4. DuPre NC, Flavin R, Sfanos KS, Unger RH, To S, Gazeeva E, Fiorentino M, De Marzo AM, Rider JR, Mucci LA. Corpora amylacea in prostatectomy tissue and associations with molecular, histological, and lifestyle factors. Prostate. 2018 Nov; 78(15):1172-1180. PMID: 30009541.
  5. Stopsack KH, Ebot EM, Downer MK, Gerke TA, Rider JR, Kantoff PW, Mucci LA. Regular aspirin use and gene expression profiles in prostate cancer patients. Cancer Causes Control. 2018 Jun 18. PMID: 29915914.
  6. Sinnott JA, Brumberg K, Wilson KM, Ebot EM, Giovannucci EL, Mucci LA, Rider JR. Differential Gene Expression in Prostate Tissue According to Ejaculation Frequency. Eur Urol. 2018 11; 74(5):545-548. PMID: 29784192.
  7. Erlandsson A, Carlsson J, Andersson SO, Vyas C, Wikström P, Andrén O, Davidsson S, Rider JR. High inducible nitric oxide synthase in prostate tumor epithelium is associated with lethal prostate cancer. Scand J Urol. 2018 Apr; 52(2):129-133. PMID: 29307261; DOI: 10.1080/21681805.2017.1421261;.
  8. Börnigen D, Ren B, Pickard R, Li J, Ozer E, Hartmann EM, Xiao W, Tickle T, Rider J, Gevers D, Franzosa EA, Davey ME, Gillison ML, Huttenhower C. Alterations in oral bacterial communities are associated with risk factors for oral and oropharyngeal cancer. Sci Rep. 2017 Dec 15; 7(1):17686. PMID: 29247187.
  9. Davidsson S, Andren O, Ohlson AL, Carlsson J, Andersson SO, Giunchi F, Rider JR, Fiorentino M. FOXP3+ regulatory T cells in normal prostate tissue, postatrophic hyperplasia, prostatic intraepithelial neoplasia, and tumor histological lesions in men with and without prostate cancer. Prostate. 2018 Jan; 78(1):40-47. PMID: 29105795.
  10. Stopsack KH, Gerke TA, Andrén O, Andersson SO, Giovannucci EL, Mucci LA, Rider JR. Cholesterol uptake and regulation in high-grade and lethal prostate cancers. Carcinogenesis. 2017 08 01; 38(8):806-811. PMID: 28595267.
Showing 10 of 90 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 90 publications over 14 distinct years, with a maximum of 17 publications in 2016

In addition to these self-described keywords below, a list of MeSH based concepts is available here.

cancer etiology
infection-associated cancers
prostate cancer
gene expression
prognostic tools

I am interested in mentoring graduate students and clinicians with an interest in cancer disparities, cancer prevention, or prognostic/predictive biomarkers.

Available to Mentor as: (Review Mentor Role Definitions):
  • Project Mentor
  • Research / Scholarly Mentor
Contact for Mentoring:
  • Email (see 'Contact Info')

715 Albany St Talbot Building
Boston MA 02118
Google Map

Rider's Networks
Click the "See All" links for more information and interactive visualizations
Similar People
Same Department